✦ LIBER ✦

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: A FONICAP randomised phase II study

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitomycin-ifosfamide-platinum (MIP) vs m

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Cisplatin-vindesine-mitomycin (MVP) vs c

✍ Baldini, E; Tibaldi, C; Ardizzoni, A; Salvati, F; Antilli, A; Portalone, L; Barb 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 683 KB

Results of a phase II study using MIP re

✍ Dutin, J.P.; Lacroix, H.; Donnadieu, N.; Cumin, I.; Dabouis, G. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB

PD-086 A phase II randomised study of ge

✍ Brechot, J.; Saintigny, P.; Azorin, J.; Valeyre, D.; Breau, J.; Morere, J.; Gnom 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Phase II study with mitomycin, ifosfamid

✍ A. von Rohr; H. Anderson; R. McIntosh; N. Thatcher 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 348 KB

25 Randomized phase II study of cisplati

✍ Morere, Jean-Francois; Spano, Jean-Philippe; Pailler, Marie-Christine; Bouillet, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 197 KB